Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan

NCT00496873 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Cytoxan
DRUG: Nipent
DRUG: Rituxan

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]